Works by Heuvel, Michel M van den

Results: 56
    1

    The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort Study.

    Published in:
    Clinical Lung Cancer, 2025, v. 26, n. 4, p. 324, doi. 10.1016/j.cllc.2025.03.010
    By:
    • Kicken, Mart P.;
    • Heine, Rob Ter;
    • Azarfane, Intissar;
    • de Rouw, Nikki;
    • de Vries, Fenna;
    • Peters, Bas J. M.;
    • Lankheet, Nienke A. G.;
    • Eektimmerman, Frank;
    • Beerden, Tim;
    • Franssen, Eric J. F.;
    • Krens, Lisanne L.;
    • van der Leest, Cor H.;
    • Smit, Arthur A. J.;
    • Polman, Albert J.;
    • Vermeer, Laura C.;
    • van Putten, John W. G.;
    • van den Borne, Ben E. E. M.;
    • van den Heuvel, Michel M.;
    • Deenen, Maarten J.
    Publication type:
    Article
    2
    3
    4

    Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 5, p. 789, doi. 10.1007/s11523-024-01075-8
    By:
    • Moes, Dirk J. A. R.;
    • Hendrikx, Jeroen J. M. A.;
    • Guchelaar, Henk-Jan;
    • Mathijssen, Ron H. J.;
    • Bakker, J. L.;
    • Dezentjé, Vincent O.;
    • de Rouw, Nikki;
    • van Erp, Nielka P.;
    • Smit, Egbert F.;
    • van den Heuvel, Michel M.;
    • Munnink, Thijs H. Oude;
    • van Kats, Maartje;
    • Croes, Sander;
    • Kroep, Judith R.;
    • Zwaveling, Juliette;
    • ter Heine, Rob
    Publication type:
    Article
    5

    A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer.

    Published in:
    Targeted Oncology, 2023, v. 18, n. 3, p. 441, doi. 10.1007/s11523-023-00958-6
    By:
    • ter Heine, Rob;
    • van den Heuvel, Michel M.;
    • Piet, Berber;
    • Deenen, Maarten J.;
    • van der Wekken, Anthonie J.;
    • Hendriks, Lizza E. L.;
    • Croes, Sander;
    • van Geel, Robin M. J. M.;
    • Jansman, Frank G. A.;
    • Boshuizen, Rogier C.;
    • Franssen, Eric J. F.;
    • Smit, Arthur A. J.;
    • Dumoulin, Daphne W.;
    • Oude Munnink, Thijs H.;
    • Smit, Egbert F.;
    • Derijks, Hieronymus J.;
    • van der Leest, Cor H.;
    • Hendrikx, Jeroen J. M. A.;
    • Moes, Dirk J. A. R.;
    • de Rouw, Nikki
    Publication type:
    Article
    6
    7
    8
    9

    Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial.

    Published in:
    2017
    By:
    • Jänne, Pasi A.;
    • van den Heuvel, Michel M.;
    • Barlesi, Fabrice;
    • Cobo, Manuel;
    • Mazieres, Julien;
    • Crinò, Lucio;
    • Orlov, Sergey;
    • Blackhall, Fiona;
    • Wolf, Juergen;
    • Garrido, Pilar;
    • Poltoratskiy, Artem;
    • Mariani, Gabriella;
    • Ghiorghiu, Dana;
    • Kilgour, Elaine;
    • Smith, Paul;
    • Kohlmann, Alexander;
    • Carlile, David J.;
    • Lawrence, David;
    • Bowen, Karin;
    • Vansteenkiste, Johan
    Publication type:
    journal article
    10

    Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 1, p. 33, doi. 10.1007/s00280-022-04489-1
    By:
    • de Rouw, Nikki;
    • Boosman, René J.;
    • Burgers, Jacobus A.;
    • Huitema, Alwin D. R.;
    • Dingemans, Anne-Marie C.;
    • Derijks, Hieronymus. J.;
    • Burger, David M.;
    • Piet, Berber;
    • Hendriks, Lizza E. L.;
    • Biesma, Bonne;
    • Pruis, Melinda A.;
    • Dumoulin, Daphne W.;
    • Croes, Sander;
    • Mathijssen, Ron H. J.;
    • van den Heuvel, Michel M.;
    • ter Heine, Rob
    Publication type:
    Article
    11
    12
    13
    14

    Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC).

    Published in:
    Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1136221
    By:
    • Meertens, Marinda;
    • Muntinghe-Wagenaar, M. Benthe;
    • Sikkema, Barend J.;
    • Lopez-Yurda, Marta;
    • Retèl, Valesca P.;
    • Paats, Marthe S.;
    • Heine, Rob Ter;
    • Schuuring, Ed;
    • Timens, Wim;
    • Touw, Daan J.;
    • van Boven, Job F. M.;
    • de Langen, Adrianus. J.;
    • Hashemi, Sayed M. S.;
    • Hendriks, Lizza E. L.;
    • Croes, Sander;
    • van den Heuvel, Michel M.;
    • Dingemans, Anne-Marie C.;
    • Mathijssen, Ron H. J.;
    • Smit, Egbert F.;
    • Huitema, Alwin D. R.
    Publication type:
    Article
    15

    Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation.

    Published in:
    International Journal of Cancer, 2015, v. 136, n. 6, p. 1434, doi. 10.1002/ijc.29113
    By:
    • Groenendijk, Floris H.;
    • Mellema, Wouter W.;
    • van der Burg, Eline;
    • Schut, Eva;
    • Hauptmann, Michael;
    • Horlings, Hugo M.;
    • Willems, Stefan M.;
    • van den Heuvel, Michel M.;
    • Jonkers, Jos;
    • Smit, Egbert F.;
    • Bernards, René
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity.

    Published in:
    Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01521
    By:
    • van den Broek, Daan;
    • Hiltermann, T. Jeroen N.;
    • Biesma, Bonne;
    • Dinjens, Winand N. M.;
    • 't Hart, Nils A.;
    • Hinrichs, John W. J.;
    • Leers, Mathie P. G.;
    • Monkhorst, Kim;
    • van Oosterhout, Matthijs;
    • Scharnhorst, Volkher;
    • Schuuring, Ed;
    • Speel, Ernst-Jan M.;
    • van den Heuvel, Michel M.;
    • van Schaik, Ron H. N.;
    • von der Thüsen, Jan;
    • Willems, Stefan M.;
    • de Visser, Leonie;
    • Ligtenberg, Marjolijn J. L.
    Publication type:
    Article
    28

    Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity.

    Published in:
    Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2019.01521
    By:
    • van den Broek, Daan;
    • Hiltermann, T. Jeroen N.;
    • Biesma, Bonne;
    • Dinjens, Winand N. M.;
    • 't Hart, Nils A.;
    • Hinrichs, John W. J.;
    • Leers, Mathie P. G.;
    • Monkhorst, Kim;
    • van Oosterhout, Matthijs;
    • Scharnhorst, Volkher;
    • Schuuring, Ed;
    • Speel, Ernst-Jan M.;
    • van den Heuvel, Michel M.;
    • van Schaik, Ron H. N.;
    • von der Thüsen, Jan;
    • Willems, Stefan M.;
    • de Visser, Leonie;
    • Ligtenberg, Marjolijn J. L.
    Publication type:
    Article
    29
    30
    31

    Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies.

    Published in:
    Oncologist, 2017, v. 22, n. 1, p. 33, doi. 10.1634/theoncologist.2016-0085
    By:
    • Bins, Sander;
    • Cirkel, Geert A.;
    • Gadellaa‐Van Hooijdonk, Christa G.;
    • Weeber, Fleur;
    • Numan, Isaac J.;
    • Bruggink, Annette H.;
    • van Diest, Paul J.;
    • Willems, Stefan M.;
    • Veldhuis, Wouter B.;
    • van den Heuvel, Michel M.;
    • de Knegt, Rob J.;
    • Koudijs, Marco J.;
    • van Werkhoven, Erik;
    • Mathijssen, Ron H.J.;
    • Cuppen, Edwin;
    • Sleijfer, Stefan;
    • Schellens, Jan H.M.;
    • Voest, Emile E.;
    • Langenberg, Marlies H.G.;
    • de Jonge, Maja J.A.
    Publication type:
    Article
    32
    33

    Toxicity of pemetrexed during renal impairment explained—Implications for safe treatment.

    Published in:
    International Journal of Cancer, 2021, v. 149, n. 8, p. 1576, doi. 10.1002/ijc.33721
    By:
    • Boosman, René J.;
    • Dorlo, Thomas P. C.;
    • de Rouw, Nikki;
    • Burgers, Jacobus A.;
    • Dingemans, Anne‐Marie C.;
    • van den Heuvel, Michel M.;
    • Hendriks, Lizza E. L.;
    • Biesma, Bonne;
    • Aerts, Joachim G. J. V.;
    • Croes, Sander;
    • Mathijssen, Ron H. J.;
    • Huitema, Alwin D. R.;
    • ter Heine, Rob
    Publication type:
    Article
    34
    35

    Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study.

    Published in:
    PLoS Medicine, 2025, v. 22, n. 4, p. 1, doi. 10.1371/journal.pmed.1004574
    By:
    • Schuurbiers, Milou M. F.;
    • Smith, Christopher G.;
    • Hartemink, Koen J.;
    • Rintoul, Robert C.;
    • Gale, Davina;
    • Monkhorst, Kim;
    • Mandos, Bas L. R.;
    • Paterson, Anna L.;
    • van den Broek, Dan;
    • Rosenfeld, Nitzan;
    • van den Heuvel, Michel M.
    Publication type:
    Article
    36
    37
    38

    Hyperhydration with cisplatin does not influence pemetrexed exposure.

    Published in:
    British Journal of Clinical Pharmacology, 2022, v. 88, n. 2, p. 871, doi. 10.1111/bcp.15031
    By:
    • de Rouw, Nikki;
    • Derijks, Hieronymus J.;
    • Hilbrands, Luuk B.;
    • Boosman, René J.;
    • Piet, Berber;
    • Koolen, Stijn L. W.;
    • Burgers, Jacobus A.;
    • Dingemans, Anne‐Marie C.;
    • van den Heuvel, Michel M.;
    • Hendriks, Lizza E. L.;
    • Aerts, Joachim G. J. V.;
    • Croes, Sander;
    • Mathijssen, Ron H. J.;
    • Huitema, Alwin D. R.;
    • Burger, David M.;
    • Biesma, Bonne;
    • ter Heine, Rob
    Publication type:
    Article
    39

    Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis.

    Published in:
    Interactive Cardiovascular & Thoracic Surgery, 2022, v. 34, n. 4, p. 566, doi. 10.1093/icvts/ivab291
    By:
    • Joosten, Pieter J M;
    • Dickhoff, Chris;
    • van der Noort, Vincent;
    • Smeekens, Maarten;
    • Numan, Rachel C;
    • Klomp, Houke M;
    • Diessen, Judi N A van;
    • Belderbos, Jose S A;
    • Smit, Egbert F;
    • Monkhorst, Kim;
    • Oosterhuis, Jan W A;
    • Heuvel, Michel M van den;
    • Dahele, Max;
    • Hartemink, Koen J
    Publication type:
    Article
    40
    41

    Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.

    Published in:
    PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216864
    By:
    • Theelen, Willemijn S. M. E.;
    • Kuilman, Thomas;
    • Schulze, Katja;
    • Zou, Wei;
    • Krijgsman, Oscar;
    • Peters, Dennis D. G. C.;
    • Cornelissen, Sten;
    • Monkhorst, Kim;
    • Sarma, Pranamee;
    • Sumiyoshi, Teiko;
    • Amler, Lukas C.;
    • Willems, Stefan M.;
    • Blaauwgeers, Johannes L. G.;
    • van Noesel, Carel J. M.;
    • Peeper, Daniel S.;
    • van den Heuvel, Michel M.;
    • Kowanetz, Marcin
    Publication type:
    Article
    42
    43
    44
    45

    Development and validation of an ultra‐performance liquid chromatography–tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasma

    Published in:
    Biomedical Chromatography, 2024, v. 38, n. 10, p. 1, doi. 10.1002/bmc.5986
    By:
    • Hollander, Esther M.;
    • Zimmerman, Nachel M. C.;
    • Piet, Berber;
    • van den Heuvel, Michel M.;
    • Burger, David M.;
    • te Brake, Lindsey H. M.;
    • ter Heine, Rob
    Publication type:
    Article
    46
    47
    48
    49
    50